The benefits of testosterone replacement therapy are many. It boosts libido, lowers your risk of heart disease, and lowers prostate cancer, just to name a few. There are also a number of drawbacks. Let's take a closer look. What's the right choice for you? click this link here now
Testosterone replacement therapy, or TRT, restores the sex drive in older men with hypogonadism. In addition to improving libido, TRT can help with performance problems such as erectile dysfunction. A doctor can prescribe oral medications or testosterone injections. These procedures can cost up to $400 a month and aren't always covered by insurance. Several studies have shown that testosterone replacement therapy improves sex drive. However, some side effects may result from the treatment.
A recent study found that testosterone therapy increased interest and activity in sex in older men with low libido. The study, known as the Testosterone Trials, included seven studies looking at the effects of testosterone therapy in men 65 years old and older. It found that treatment increased libido and improved 10 out of 12 sexual function measurements, including frequency of intercourse, nighttime erections, and masturbation. In addition, men who received testosterone therapy had significantly improved erectile function and increased attention to erotic cues.
A reduction in testosterone levels can affect both the physical and emotional well-being of an individual. A man may not feel sexually engaged or sexy, or he may become physically weaker and lose sex drive. Regardless of the cause, low testosterone levels are detrimental to sexual function.
Lowers risk of prostate cancer
Eating a healthy diet with plenty of fiber is essential for prostate health. Foods rich in fiber include whole grains, fruits, vegetables and legumes. Men should also limit their intake of red meat, as this is high in saturated fat. A higher consumption of fruits and vegetables is linked to a lower risk of prostate cancer. In addition, increasing consumption of antioxidant-rich foods such as tomatoes and broccoli may also help lower the risk of prostate cancer.
In addition to regular exercise, men should limit their intake of alcohol and tobacco products. Alcohol and smoking are associated with increased prostate cancer risk. However, red wine may help reduce the risk if consumed in moderation. Some studies suggest at least four five-ounce glasses a week. Additionally, being overweight or obese is linked to a higher risk of prostate cancer. It is important to maintain a healthy weight and get regular exercise to boost your immune system.
Studies on the effect of omega-3 fatty acids on the risk of prostate cancer have mixed results. While some people report a reduced risk of prostate cancer after eating more fruit, this is not conclusive.
Increases risk of heart attack
A new study found that men who undergo testosterone therapy are at greater risk of heart attack. The hormone is involved in a variety of cardiovascular problems, including increased blood pressure and a reduced HDL cholesterol level. The findings have prompted the FDA to issue a warning about the potential risk of testosterone therapy. This has led to a decline in the number of prescriptions for the drug and a decline in testosterone sales in the U.S. However, the European Medicines Agency has concluded that there is insufficient evidence to draw any conclusive conclusions about this controversial treatment.
Researchers found that older men who used testosterone gel had a significantly increased risk of developing coronary artery plaque. The waxy substance in the plaque can harden and reduce the flow of oxygen to the heart. This blockage can cause a heart attack. However, these risks were not limited to older men. For men younger than 65 with a history of heart disease, the risk was two to three times higher.
This study addresses the FDA's mandate requiring manufacturers to include warnings about cardiovascular risks associated with testosterone supplementation. The researchers from the Intermountain Medical Center will present their findings at the 65th Annual Scientific Meeting of the American College of Cardiology. The study's authors include Tam L. Bair, Heidi L. May, Viet Le, and Jeffrey L. Anderson.